References
- Giovannelli I, Heath P, Shaw PJ, Kirby J. The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential. Amyotrophic Lateral Sclerosis Frontotemporal Degen. 2020. https://doi.org/10.1080/21678421.2020.1752246.
- Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, et al. NurOwn, phase 2, randomized, clinical trial in patients with ALS. Neurology. 2019;93:e2294–e2305.
- Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical Trials. JAMA Neurol. 2016;73:337–44.
- Gravel M, Béland L-C, Soucy G, Abdelhamid E, Rahimian R, Gravel C, et al. IL-10 controls early microglial phenotypes and disease onset in als caused by misfolded superoxide dismutase 1. J Neurosci. 2016;36:1031–48.
- Pennati A, Ng S, Wu Y, Murphy JR, Deng J, Rangaraju S, et al. Regulatory B cells induce formation of IL-10-expressing t cells in mice with autoimmune neuroinflammation. J Neurosci. 2016;36:12598–610.
- Anderson WD, Greenhalgh AD, Takwale A, David S, Vadigepalli R. Novel influences of IL-10 on CNS inflammation revealed by integrated analyses of cytokine networks and microglial morphology. Front. Cell. Neurosci 2017;11. https://doi.org/10.3389/fncel.2017.00233
- Pennati A, Asress S, Glass JD, Galipeau J. Adoptive transfer of IL-10+ regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis model. Cell Mol Immunol. 2018;15:727–30.